Therapeutic Targeting of Ependymoma As Informed By Oncogenic Enhancer Profiling

— Categories: Ependymoma Research Articles     Posted on January 9, 2018

Scientists have now developed a molecular approach that may open new treatment prospects for ependymoma.

The genetic causes for ependymomas development are largely unknown and there are no targeted treatments to date. In the quest for novel therapeutic approaches in the treatment of ependymoma, scientists began testing an alternative approach. They took a closer look at so-called enhancers, regions of the genome that regulate the activity of genes. They were able to demonstrate that these enhancer elements regulate molecules that are involved in key cellular processes and may therefore be used as targets for targeted therapies. Info provided by: German Cancer Research Center.

To read the Nature article, click here.

Stay Informed with the CERN Newsletter

The CERN Foundation is committed to informing you with the latest ependymoma news and research. Join our mailing list for monthly updates. View all newsletters